Detalles de la búsqueda
1.
Diabetes remission in drug-naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort study.
Diabetes Obes Metab
; 25(10): 2878-2887, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385967
2.
Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin.
Endocr Pract
; 27(8): 790-797, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33831552
3.
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trial.
Diabetes Obes Metab
; 20(4): 1006-1013, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29227571
4.
[Efficacy and safety of alogliptin in treatment of type 2 diabetes mellitus: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial in mainland China].
Zhonghua Nei Ke Za Zhi
; 54(11): 949-53, 2015 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-26759214
5.
[The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China].
Zhonghua Nei Ke Za Zhi
; 52(11): 932-5, 2013 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-24439186
6.
Correlation analysis of serum IGF-1 and IL-6 and urinary albumin/creatinine ratio in patients with type 2 diabetic kidney disease.
Front Endocrinol (Lausanne)
; 13: 1082492, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36568065
7.
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial.
Nat Med
; 28(5): 974-981, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551292
8.
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial.
Nat Med
; 28(5): 965-973, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551294
9.
Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.
J Diabetes Investig
; 12(4): 537-545, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32810383
10.
Knockdown of lncRNA PVT1 alleviates high glucose-induced proliferation and fibrosis in human mesangial cells by miR-23b-3p/WT1 axis.
Diabetol Metab Syndr
; 12: 33, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32322310
11.
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Diabetes Endocrinol
; 6(8): 627-636, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29735394
12.
Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong.
J Diabetes
; 9(4): 386-395, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27171508
Resultados
1 -
12
de 12
1
Próxima >
>>